These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19434502)

  • 1. Simulations of the nonlinear dose dependence for substrates of influx and efflux transporters in the human intestine.
    Bolger MB; Lukacova V; Woltosz WS
    AAPS J; 2009 Jun; 11(2):353-63. PubMed ID: 19434502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters.
    Landowski CP; Sun D; Foster DR; Menon SS; Barnett JL; Welage LS; Ramachandran C; Amidon GL
    J Pharmacol Exp Ther; 2003 Aug; 306(2):778-86. PubMed ID: 12750437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of peptide transporter 1 in the intestinal permeability of valacyclovir in wild-type and PepT1 knockout mice.
    Yang B; Smith DE
    Drug Metab Dispos; 2013 Mar; 41(3):608-14. PubMed ID: 23264448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico Absorption Analysis of Valacyclovir in Wildtype and Pept1 Knockout Mice Following Oral Dose Escalation.
    Yang B; Smith DE
    Pharm Res; 2017 Nov; 34(11):2349-2361. PubMed ID: 28770489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico modeling of non-linear drug absorption for the P-gp substrate talinolol and of consequences for the resulting pharmacodynamic effect.
    Tubic M; Wagner D; Spahn-Langguth H; Bolger MB; Langguth P
    Pharm Res; 2006 Aug; 23(8):1712-20. PubMed ID: 16832615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro evaluations of intestinal gabapentin absorption: effect of dose and inhibitors on carrier-mediated transport.
    Larsen MS; Frølund S; Nøhr MK; Nielsen CU; Garmer M; Kreilgaard M; Holm R
    Pharm Res; 2015 Mar; 32(3):898-909. PubMed ID: 25182974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in rats.
    Sinko PJ; Balimane PV
    Biopharm Drug Dispos; 1998 May; 19(4):209-17. PubMed ID: 9604120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDR1 genotypes do not influence the absorption of a single oral dose of 600 mg valacyclovir in healthy Chinese Han ethnic males.
    Zhang Y; Jiang XH; Hu YQ; Li ZR; Su L; Wang ZG; Ma G
    Br J Clin Pharmacol; 2008 Aug; 66(2):247-54. PubMed ID: 18460034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of peptide transporter 1 on the intestinal absorption and pharmacokinetics of valacyclovir after oral dose escalation in wild-type and PepT1 knockout mice.
    Yang B; Hu Y; Smith DE
    Drug Metab Dispos; 2013 Oct; 41(10):1867-74. PubMed ID: 23924683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor.
    Phan DD; Chin-Hong P; Lin ET; Anderle P; Sadee W; Guglielmo BJ
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2351-3. PubMed ID: 12821497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: I. Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters.
    Cundy KC; Branch R; Chernov-Rogan T; Dias T; Estrada T; Hold K; Koller K; Liu X; Mann A; Panuwat M; Raillard SP; Upadhyay S; Wu QQ; Xiang JN; Yan H; Zerangue N; Zhou CX; Barrett RW; Gallop MA
    J Pharmacol Exp Ther; 2004 Oct; 311(1):315-23. PubMed ID: 15146028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration-dependent effect of naringin on intestinal absorption of beta(1)-adrenoceptor antagonist talinolol mediated by p-glycoprotein and organic anion transporting polypeptide (Oatp).
    Shirasaka Y; Li Y; Shibue Y; Kuraoka E; Spahn-Langguth H; Kato Y; Langguth P; Tamai I
    Pharm Res; 2009 Mar; 26(3):560-7. PubMed ID: 19002566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico modeling for the nonlinear absorption kinetics of UK-343,664: a P-gp and CYP3A4 substrate.
    Abuasal BS; Bolger MB; Walker DK; Kaddoumi A
    Mol Pharm; 2012 Mar; 9(3):492-504. PubMed ID: 22264132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L503F variant of carnitine/organic cation transporter 1 efficiently transports metformin and other biguanides.
    Futatsugi A; Masuo Y; Kawabata S; Nakamichi N; Kato Y
    J Pharm Pharmacol; 2016 Sep; 68(9):1160-9. PubMed ID: 27350110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic effects of simultaneous administration of single-dose gabapentin 500 mg and zolpidem tartrate 10 mg in healthy volunteers: a randomized, open-label, crossover trial.
    Galitz LA; Jayawardena S; Furey SA
    Drugs R D; 2015 Mar; 15(1):71-7. PubMed ID: 25567214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of P-glycoprotein-mediated intestinal efflux kinetics on oral bioavailability of P-glycoprotein substrates.
    Kwon H; Lionberger RA; Yu LX
    Mol Pharm; 2004; 1(6):455-65. PubMed ID: 16028357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin.
    Urban TJ; Brown C; Castro RA; Shah N; Mercer R; Huang Y; Brett CM; Burchard EG; Giacomini KM
    Clin Pharmacol Ther; 2008 Mar; 83(3):416-21. PubMed ID: 17609685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat.
    Shirasaka Y; Kuraoka E; Spahn-Langguth H; Nakanishi T; Langguth P; Tamai I
    J Pharmacol Exp Ther; 2010 Jan; 332(1):181-9. PubMed ID: 19779132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population pharmacokinetic model of gabapentin developed in nonparametric adaptive grid and nonlinear mixed effects modeling.
    Carlsson KC; van de Schootbrugge M; Eriksen HO; Moberg ER; Karlsson MO; Hoem NO
    Ther Drug Monit; 2009 Feb; 31(1):86-94. PubMed ID: 19077930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of acyclovir in children and young people with malignancy after administration of intravenous acyclovir or oral valacyclovir.
    Zeng L; Nath CE; Blair EY; Shaw PJ; Stephen K; Earl JW; Coakley JC; McLachlan AJ
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2918-27. PubMed ID: 19414579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.